Petros pharmaceuticals responds to fraudulent press release

New york, july 28, 2022 (globe newswire) -- petros pharmaceuticals, inc. (nasdaq: ptpi), a leading provider of therapeutics for men's health, today confirmed that a press release issued on july 28, 2022 regarding a purported acquisition of the company was fraudulent and not issued by the company. the company is not a party to any such acquisition and has reported the fraudulent activity to nasdaq.

PTPI Ratings Summary

PTPI Quant Ranking